<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39022343</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>The existence of adrenal insufficiency in patients with COVID-19 pneumonia.</ArticleTitle><Pagination><StartPage>1337652</StartPage><MedlinePgn>1337652</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1337652</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2024.1337652</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Infection with SARS-CoV-2 virus may result in long COVID, a syndrome characterized by symptoms such as dyspnea, cardiac abnormalities, cognitive impairment, and fatigue. One potential explanation for these symptoms is hypocortisolism.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the prevalence of hypocortisolism in patients with a history of COVID-19 pneumonia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cross-sectional study of patients who were aged &#x2265;18 years and had a 3-month history of radiography-confirmed COVID-19 pneumonia. Exclusion criteria included current or previous treatment with glucocorticoids and use of an oral contraceptive. Adrenal function was evaluated using a low dose (1ug) corticotropin stimulation test (CST). Serum cortisol levels were measured at 0, 30, and 60 minutes, and baseline plasma ACTH was also measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 41 patients enrolled, the median age was 62 years, 17 (42%) were female, and all 41 (100%) had severe pneumonia at baseline. Eleven patients (27%) had hypocortisolism, as evidenced by peak cortisol of less than 402.81 nmol/l after low dose (1 &#xb5;g) CST. Of these 11 patients, 10 (91%) had secondary hypocortisolism (median ACTH 6.27 pmol/L, range 4.98-9.95 pmol/L) and one had primary hypocortisolism (mean ACTH 32.78 pmol/L). Six of the 11 patients with hypocortisolism (54.5%) reported symptoms of persistent fatigue and 5 (45.5%) required regular glucocorticoid replacement.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our results suggest that hypocortisolism, predominantly caused by pituitary disruption, may emerge after SARS-CoV-2 infection and should be considered in patients with a history of COVID-19 pneumonia with or without clinical hypocortisolism.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Porntharukchareon, Dechates, Sirisreetreerux, Therawit and Tawinprai.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Porntharukchareon</LastName><ForeName>Thachanun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dechates</LastName><ForeName>Bothamai</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirisreetreerux</LastName><ForeName>Supamas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Therawit</LastName><ForeName>Phonthip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tawinprai</LastName><ForeName>Kriangkrai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9002-60-2</RegistryNumber><NameOfSubstance UI="D000324">Adrenocorticotropic Hormone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000309" MajorTopicYN="Y">Adrenal Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="Y">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000324" MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pneumonia</Keyword><Keyword MajorTopicYN="N">adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">hypocortisolism</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">low dose synacthen test</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>18</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39022343</ArticleId><ArticleId IdType="pmc">PMC11251879</ArticleId><ArticleId IdType="doi">10.3389/fendo.2024.1337652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Organization WH . WHO Coronavirus (COVID-19) Dashboard (2022). Available online at: https://covid19.who.int.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus (2021). Available online at: https://apps.who.int/iris/handle/10665/345824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. . Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. (2020) 251:228&#x2013;48. doi:&#xa0;10.1002/path.5471</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne). (2023) 10:1011936. doi:&#xa0;10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). (2005) 63:197&#x2013;202. doi:&#xa0;10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Therapeutics and COVID-19: living guideline, 16 September 2022. World Health Organization. (2022). Available at: https://iris.who.int/handle/10665/362843.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917393</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Yao L, Tan Y, Shen Z, Zheng H, Zhou H, et al. . Quantitative and semi-quantitative CT assessments of lung lesion burden in COVID-19 pneumonia. Sci Rep. (2021) 11:5148. doi:&#xa0;10.1038/s41598-021-84561-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84561-7</ArticleId><ArticleId IdType="pmc">PMC7933172</ArticleId><ArticleId IdType="pubmed">33664342</ArticleId></ArticleIdList></Reference><Reference><Citation>Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colon-Franco JM, et al. . New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. (2021) 5:bvab022. doi:&#xa0;10.1210/jendso/bvab022</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab022</ArticleId><ArticleId IdType="pmc">PMC7975762</ArticleId><ArticleId IdType="pubmed">33768189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongioi LM, Condorelli RA, Barbagallo F, Cannarella R, La Vignera S, Calogero AE. Accuracy of the low-dose ACTH stimulation test for adrenal insufficiency diagnosis: A re-assessment of the cut-off value. J Clin Med. (2019) 8. doi:&#xa0;10.3390/jcm8060806</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8060806</ArticleId><ArticleId IdType="pmc">PMC6616948</ArticleId><ArticleId IdType="pubmed">31195750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. . Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. (2016) 101:364&#x2013;89. doi:&#xa0;10.1210/jc.2015-1710</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2015-1710</ArticleId><ArticleId IdType="pmc">PMC4880116</ArticleId><ArticleId IdType="pubmed">26760044</ArticleId></ArticleIdList></Reference><Reference><Citation>Enderlein G, Wayne W. Biostatistics &#x2014; A foundations for analysis in the health sciences. Wiley &amp; Sons, new york&#x2014;Chichester&#x2014;Brisbane&#x2014;Toronto&#x2014;Singapore, 6th ed. 1995, 780 S., &#xa3;58.&#x2014;, ISBN 0&#x2013;471&#x2013;58852&#x2013;0 (cloth). Biometrical J. (1995) 37:744&#x2013;. doi:&#xa0;10.1002/bimj.4710370610</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.4710370610</ArticleId></ArticleIdList></Reference><Reference><Citation>Allora A, Castellino L, di Filippo L, Loli P, Giustina A. COVID-19 and the pituitary. Pituitary. (2021) 24:465&#x2013;81. doi:&#xa0;10.1007/s11102-021-01148-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-021-01148-1</ArticleId><ArticleId IdType="pmc">PMC8089131</ArticleId><ArticleId IdType="pubmed">33939057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;80 e8. doi:&#xa0;10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. . Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. (2004) 203:622&#x2013;30. doi:&#xa0;10.1002/path.1560</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T, Kang J, Li G, Ge J, Gu J. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study. Ann Transl Med. (2020) 8:1077. doi:&#xa0;10.21037/atm</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm</ArticleId><ArticleId IdType="pmc">PMC7576005</ArticleId><ArticleId IdType="pubmed">33145296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K, Nishigaki T, Kuramoto N, Oh K, Konishi H. Secondary adrenal insufficiency after COVID-19 diagnosed by insulin tolerance test and corticotropin-releasing hormone test. Cureus. (2022) 14:e23021. doi:&#xa0;10.7759/cureus.23021</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23021</ArticleId><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="pubmed">35281581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh AB, Javed N, Sheikh AAE, Upadhyay S, Shekhar R. Diabetes insipidus and concomitant myocarditis: A late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep. (2021) 9:2324709621999954. doi:&#xa0;10.1177/2324709621999954</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709621999954</ArticleId><ArticleId IdType="pmc">PMC7952841</ArticleId><ArticleId IdType="pubmed">33686899</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavari A, Sharifan Z, Larijani B, Mosadegh Khah A. Central diabetes insipidus secondary to COVID-19 infection: a case report. BMC Endocr Disord. (2022) 22:134. doi:&#xa0;10.1186/s12902-022-01048-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-022-01048-w</ArticleId><ArticleId IdType="pmc">PMC9117597</ArticleId><ArticleId IdType="pubmed">35590312</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgar RA, Rasool A, Wani AI, Bashir MI. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J Endocrinol Invest. (2021). doi:&#xa0;10.1007/s40618-021-01627-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01627-z</ArticleId><ArticleId IdType="pmc">PMC8253675</ArticleId><ArticleId IdType="pubmed">34215999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew SY, Seese R, Shames A, Majumdar K. Apoplexy in a previously undiagnosed pituitary macroadenoma in the setting of recent COVID-19 infection. BMJ Case Rep. (2021) 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319972</ArticleId><ArticleId IdType="pubmed">34321266</ArticleId></ArticleIdList></Reference><Reference><Citation>Soejima Y, Otsuka Y, Tokumasu K, Nakano Y, Harada K, Nakamoto K, et al. . Late-onset hypogonadism in a male patient with long COVID diagnosed by exclusion of ME/CFS. Medicina (Kaunas). (2022) 58. doi:&#xa0;10.3390/medicina58040536</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58040536</ArticleId><ArticleId IdType="pmc">PMC9025899</ArticleId><ArticleId IdType="pubmed">35454374</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi M, Gunawardena S, Goenka A, Ey E, Kumar G. Post COVID-19 lymphocytic hypophysitis: A rare presentation. Child Neurol Open. (2022) 9:2329048X221103051. doi:&#xa0;10.1177/2329048X221103051</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2329048X221103051</ArticleId><ArticleId IdType="pmc">PMC9125064</ArticleId><ArticleId IdType="pubmed">35615060</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbova NY, Vladimirova VP, Rozhinskaya LY, Belaya ZY. [Hypophysitis and reversible hypopituitarism developed after COVID-19 infection - a clinical case report]. Probl Endokrinol (Mosk). (2022) 68:50&#x2013;6. doi:&#xa0;10.14341/probl.2022683</Citation><ArticleIdList><ArticleId IdType="doi">10.14341/probl.2022683</ArticleId><ArticleId IdType="pmc">PMC9762539</ArticleId><ArticleId IdType="pubmed">35841168</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandari D, Ziaee A, Amirfarhangi Anbardan A, Zeinali E, Tirkan A. Primary adrenal insufficiency and myocarditis in COVID-19 disease: a case report. BMC Endocr Disord. (2022) 22:336. doi:&#xa0;10.1186/s12902-022-01257-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-022-01257-3</ArticleId><ArticleId IdType="pmc">PMC9805346</ArticleId><ArticleId IdType="pubmed">36587233</ArticleId></ArticleIdList></Reference><Reference><Citation>MaChado IFR, Menezes IQ, Figueiredo SR, Coelho FMA, Terrabuio DRB, Ramos DV, et al. . Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19. J Clin Endocrinol Metab. (2021). doi:&#xa0;10.1210/clinem/dgab557</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab557</ArticleId><ArticleId IdType="pubmed">34324679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez J, Cohen M, Zapater JL, Eisenberg Y. Primary adrenal insufficiency after COVID-19 infection. AACE Clin Case Rep. (2022) 8:51&#x2013;3. doi:&#xa0;10.1016/j.aace.2021.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8590605</ArticleId><ArticleId IdType="pubmed">34805497</ArticleId></ArticleIdList></Reference><Reference><Citation>Facondo P, Maltese V, Delbarba A, Pirola I, Rotondi M, Ferlin A, et al. . Case report: hypothalamic amenorrhea following COVID-19 infection and review of literatures. Front Endocrinol (Lausanne). (2022) 13:840749. doi:&#xa0;10.3389/fendo.2022.840749</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.840749</ArticleId><ArticleId IdType="pmc">PMC9229338</ArticleId><ArticleId IdType="pubmed">35757408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem. (2022) 477:1155&#x2013;93. doi:&#xa0;10.1007/s11010-022-04356-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-022-04356-w</ArticleId><ArticleId IdType="pmc">PMC8793096</ArticleId><ArticleId IdType="pubmed">35084674</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke SA, Phylactou M, Patel B, Mills EG, Muzi B, Izzi-Engbeaya C, et al. . Normal adrenal and thyroid function in patients who survive COVID-19 infection. J Clin Endocrinol Metab. (2021) 106:2208&#x2013;20. doi:&#xa0;10.1210/clinem/dgab349</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab349</ArticleId><ArticleId IdType="pmc">PMC8194556</ArticleId><ArticleId IdType="pubmed">34008009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi PG, Shah NS, Khandelwal AG, Chauhan P, Menon PS. Evaluation of low dose ACTH stimulation test in suspected secondary adrenocortical insufficiency. J Postgrad Med. (2002) 48:280&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12571383</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E, Karaca Z, Unuvar GK, Gundogan K, Unluhizarci K. Investigation of pituitary functions after acute coronavirus disease 2019. Endocr J. (2022) 69:649&#x2013;58. doi:&#xa0;10.1507/endocrj.EJ21-0531</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ21-0531</ArticleId><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. (2015) 3:216&#x2013;26. doi:&#xa0;10.1016/S2213-8587(14)70142-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(14)70142-1</ArticleId><ArticleId IdType="pubmed">25098712</ArticleId></ArticleIdList></Reference><Reference><Citation>Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. (2014) 383:2152&#x2013;67. doi:&#xa0;10.1016/S0140-6736(13)61684-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61684-0</ArticleId><ArticleId IdType="pubmed">24503135</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaca Z, Lale A, Tanriverdi F, Kula M, Unluhizarci K, Kelestimur F. The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary. (2011) 14:134&#x2013;40. doi:&#xa0;10.1007/s11102-010-0270-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-010-0270-3</ArticleId><ArticleId IdType="pubmed">21061072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>